DRUG · Mapped RxNorm record
Rituximab
Normalized identity: rituximabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Rituximab for the Treatment of Early Rheumatoid Arthritis (RA)
NCT00396812
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedRituximab for the Treatment of Early Rheumatoid Arthritis (RA)
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
RituximabDRUG · verified · RxNorm: rituximab
Sponsors & collaborators
Autoimmunity Centers of Excellencecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00396812 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.